These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 9438677)
1. Independent interaction of alprazolam and caffeine under chronic dose regimens on differential reinforcement of low-rate (DRL 45-s) performance. Lau CE; Wang Y; Falk JL Psychopharmacology (Berl); 1997 Dec; 134(3):277-86. PubMed ID: 9438677 [TBL] [Abstract][Full Text] [Related]
2. Alprazolam, caffeine and their interaction: relating DRL performance to pharmacokinetics. Lau CE; Wang J Psychopharmacology (Berl); 1996 Jul; 126(2):115-24. PubMed ID: 8856830 [TBL] [Abstract][Full Text] [Related]
3. Differential reinforcement of low rate performance, pharmacokinetics and pharmacokinetic-pharmacodynamic modeling: independent interaction of alprazolam and caffeine. Lau CE; Wang Y; Falk JL J Pharmacol Exp Ther; 1997 Jun; 281(3):1013-29. PubMed ID: 9190832 [TBL] [Abstract][Full Text] [Related]
4. Spontaneous activity as a contingency-controlled behavior within an operant context: alprazolam concentration-effect relations after subcutaneous administration in rats. Simpao A; Sun L; Falk JL; Lau CE Psychopharmacology (Berl); 2001 May; 155(3):269-77. PubMed ID: 11432689 [TBL] [Abstract][Full Text] [Related]
5. Negligible tolerance produced by chronic intravenous alprazolam administration: a low serum drug concentration effect. Lau CE; Wang Y; Sun L; Falk JL Exp Clin Psychopharmacol; 2001 Feb; 9(1):110-6. PubMed ID: 11519626 [TBL] [Abstract][Full Text] [Related]
6. Effects of caffeine and PD 116,600 on the differential-reinforcement-of-low rate 72-S (DRL 72-S) schedule of reinforcement. Marek GJ; Heffner TG; Richards JB; Shaughnessy RA; Li AA; Seiden LS Pharmacol Biochem Behav; 1993 Aug; 45(4):987-90. PubMed ID: 8415842 [TBL] [Abstract][Full Text] [Related]
7. Behavioral effects of nicotine, amphetamine and cocaine under a fixed-interval schedule of food reinforcement in rats chronically exposed to caffeine. Jaszyna M; Gasior M; Shoaib M; Yasar S; Goldberg SR Psychopharmacology (Berl); 1998 Dec; 140(3):257-71. PubMed ID: 9877005 [TBL] [Abstract][Full Text] [Related]
8. Behavioral characterization of caffeine and adenosine agonists during chronic caffeine exposure. Newland MC; Brown K Behav Pharmacol; 1997 Feb; 8(1):17-30. PubMed ID: 9832997 [TBL] [Abstract][Full Text] [Related]
9. Dose-dependent effects but not sensitization of DRL 45-s performance by oral d-amphetamine with cumulative- and repeated-dosing regimens. Lobarinas E; Falk JL Behav Pharmacol; 1999 Dec; 10(8):739-46. PubMed ID: 10780289 [TBL] [Abstract][Full Text] [Related]
10. Quantifying the molecular structure of behavior: separate effects of caffeine, cocaine, and adenosine agonists on interresponse times and lever-press durations. Newland MC Behav Pharmacol; 1997 Feb; 8(1):1-16. PubMed ID: 9832996 [TBL] [Abstract][Full Text] [Related]
11. Changes in sensitivity of response distributions to changing reinforcement ratios during exposure to ephedrine, caffeine, and ephedrine-caffeine combinations. Borre Y; Chandrashekar S; Dougan JD; Heidenreich BA; Farmer-Dougan V Behav Pharmacol; 2007 Nov; 18(7):609-22. PubMed ID: 17912045 [TBL] [Abstract][Full Text] [Related]
12. Sensitization to amphetamine on the differential-reinforcement-of-low-rate 72-s schedule. Balcells-Olivero M; Richards JB; Seiden LS Psychopharmacology (Berl); 1997 Oct; 133(3):207-13. PubMed ID: 9361325 [TBL] [Abstract][Full Text] [Related]
13. Reinforcing effects of caffeine, ephedrine, and their binary combination in rats. Briscoe RJ; Vanecek SA; Vallett M; Baird TJ; Holloway FA; Gauvin DV Pharmacol Biochem Behav; 1998 Jul; 60(3):685-93. PubMed ID: 9678652 [TBL] [Abstract][Full Text] [Related]
14. The effects of caffeine on timing behaviour in rodents: comparisons with chlordiazepoxide. Sanger DJ Psychopharmacology (Berl); 1980; 68(3):305-9. PubMed ID: 6771817 [TBL] [Abstract][Full Text] [Related]
15. Acute effects of benzodiazepines on operant behavior and in vivo receptor binding in mice. Burke TF; Miller LG; Moerschbaecher JM Pharmacol Biochem Behav; 1994 May; 48(1):69-76. PubMed ID: 7913233 [TBL] [Abstract][Full Text] [Related]
16. Caffeine has similar pharmacokinetics and behavioral effects via the i.p. and p.o. routes of administration. Wang Y; Lau CE Pharmacol Biochem Behav; 1998 May; 60(1):271-8. PubMed ID: 9610952 [TBL] [Abstract][Full Text] [Related]
17. Tolerance to oral and IP caffeine: locomotor activity and pharmacokinetics. Lau CE; Falk JL Pharmacol Biochem Behav; 1994 Jun; 48(2):337-44. PubMed ID: 8090799 [TBL] [Abstract][Full Text] [Related]
18. Interactions between stimulants: effects on DRL performance and lethality in rats. Michaelis RC; Holloway FA; Bird DC; Huerta PL Pharmacol Biochem Behav; 1987 Jun; 27(2):299-306. PubMed ID: 3628444 [TBL] [Abstract][Full Text] [Related]
19. Effects of various drugs including organophosphorus compounds (OPC) and therapeutic compounds against OPC on DRL responding. Bizot JC Pharmacol Biochem Behav; 1998 Apr; 59(4):1069-80. PubMed ID: 9586869 [TBL] [Abstract][Full Text] [Related]
20. Flesinoxan shows antidepressant activity in a DRL 72-s screen. van Hest A; van Drimmelen M; Olivier B Psychopharmacology (Berl); 1992; 107(4):474-9. PubMed ID: 1351303 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]